About Sirion Biotech
Sirion Biotech is a company based in Planegg (Germany) founded in 2005 was acquired by PerkinElmer in June 2021. The company has 42 employees as of December 31, 2021. Sirion Biotech offers products and services including Viral Vector Products, LentiBOOST™, and AAV Capsid Development. Sirion Biotech operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Planegg, Germany
- Employees 42 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sirion Biotech Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$493.59 K (USD), Grant
Jan 01, 2016
-
Investors
PerkinElmer
& 6 more
-
Employee Count
42
as on Dec 31, 2021
-
Acquired by
PerkinElmer
(Jun 22, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sirion Biotech
Sirion Biotech offers a comprehensive portfolio of products and services, including Viral Vector Products, LentiBOOST™, and AAV Capsid Development.
Efficient vehicles for gene delivery in research purposes
Improves lentiviral transduction efficiency for cell therapy
Enhances performance of adeno-associated virus vectors
People of Sirion Biotech
Unlock access to complete
Unlock access to complete
Funding Insights of Sirion Biotech
Investors in Sirion Biotech
Sirion Biotech has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include PerkinElmer, European Union and KfW.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
High-tech industries are targeted for investments by Bayern Kapital.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Early-stage investments are made in high-tech startups by HTGF.
|
Locked | Locked | Locked |
Investor details for Sirion Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sirion Biotech
Investment portfolio details for Sirion Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sirion Biotech
Detailed financials for Sirion Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sirion Biotech Comparisons
Peer comparison for Sirion Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sirion Biotech
Sirion Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Sirion Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sirion Biotech
Complete news archive for Sirion Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sirion Biotech
Sirion Biotech was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Sirion Biotech is headquartered in Planegg, Germany. It is registered at Planegg, Bavaria, Germany.
As of Dec 31, 2021, the latest employee count at Sirion Biotech is 42.
Sirion Biotech was founded in 2005 in Planegg, Germany, operating in the biotechnology sector focused on viral vectors. Adenovirus, lentivirus, and AAV types are customized for genetic cell modeling, target validation, gene therapy, and vaccination studies. Services include virion modifications, multi-staged virus-driven cell modeling, and preclinical target research support. Cell modeling services are also provided to clients.
Sirion Biotech's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Sirion Biotech offers Viral Vector Products, LentiBOOST™, and AAV Capsid Development.
Sirion Biotech has 7 investors. Key investors include PerkinElmer, European Union, KfW, Bayern Kapital, and Creathor Venture.